Alzheimer’s Association Statement on FDA Decision to Hold Advisory Committee Meeting to Discuss Donanemab

Recognizing AIM’s March Advocate of the Month: Pamela Smith

Taking a BOLD Step to Improve Brain Health in Our Communities